Astrana Health reported 56% revenue growth and 82% adjusted EBITDA increase in Q1 2026, prompting multiple price target hikes. Baird increased its price target on Astrana Health (NASDAQ:ASTH) to $45 from $40, citing strengthening fundamentals and margin upside following Q1
Barclays cites a multi-year upstream spending cycle and higher oil prices as drivers for energy services stocks. Barclays increased its price target for Innovex International (INVX) to $26 from $24 while maintaining an Equal Weight rating. The firm highlighted the energy s
Craig-Hallum and KeyBanc lift OMCL price targets to $55 and $70 respectively following strong fiscal Q1 2026 results. Omnicell (NASDAQ:OMCL) saw its price targets raised by two firms after reporting fiscal Q1 2026 earnings. Craig-Hallum increased its target to $55 from $53
Pediatrix Medical Group reported Q1 2026 earnings of $0.36 per share and revenue growth driven by same-unit performance and acquisitions. Mizuho increased its price target for Pediatrix Medical Group (MD) to $24 from $21 after the company released Q1 2026 results. Earnings
A10 Networks, Inc. (NYSE:ATEN) is one of the best small cap stocks to buy for 10x potential. BWS Financial lifted the price target on A10 Networks, Inc. (NYSE:ATEN) to $30 from $28 on April 29, reiterating a Buy rating on the shares The firm told investors in a rese
Vermilion Energy Inc. (NYSE:VET) is one of the best small cap stocks to buy for 10x potential. Vermilion Energy Inc. (NYSE:VET) announced financial results for fiscal Q1 2026 on May 6, reporting that it generated $232 million ($1.52/basic share) of fund flows from operatio
Sionna Therapeutics, Inc. (NASDAQ:SION) is one of the best small cap stocks to buy for 10x potential. Wedbush initiated coverage of Sionna Therapeutics, Inc. (NASDAQ:SION) with an Outperform rating on May 4, setting a price target of $53 The firm told investors in a
GE Vernova GE Vernova GEV $ 1,068.23 $5.66 0.53% 50% IBD Stock Analysis GE Vernova pulls back to 21-day line, with 1,086.23 a potential entry AI energy leader starting work on new base following beat-and-raise report Relative strength line near record highs IBD Composite Rating...</strong
Intapp, Inc. (NASDAQ:INTA) is one of the best small cap stocks to buy for 10x potential. Intapp, Inc. (NASDAQ:INTA) received several rating updates following the release of its financial results for fiscal Q3 2026 on May 5 Barclays lifted the price target on the sto
Inhibrx Biosciences, Inc. (NASDAQ:INBX) is one of the best small cap stocks to buy for 10x potential. Inhibrx Biosciences, Inc. (NASDAQ:INBX) announced on May 11 positive interim results from the randomized, first-line Phase 2 portion of the HexAgon study, with the trial e
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.